| Active Solutions Therapy Serv Inc | |
|
1 Linnie Ct, Edgewood, NM 87015-9125 | |
| (505) 286-7838 | |
| (505) 286-8025 |
| Full Name | Active Solutions Therapy Serv Inc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist - Orthopedic |
| Location | 1 Linnie Ct, Edgewood, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720075880 | NPI | - | NPPES |
| E2935 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2251X0800X | Physical Therapist - Orthopedic | 1666 (New Mexico) | Primary |
| Provider Name | Valerie A Gove |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1699810267 PECOS PAC ID: 1951390699 Enrollment ID: I20040508000239 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Tony L Rusk |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1689652117 PECOS PAC ID: 8527016708 Enrollment ID: I20050225000400 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Marybeth C Plummer |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1245418367 PECOS PAC ID: 3779533658 Enrollment ID: I20050318000043 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Sandra K Chavez |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1952389488 PECOS PAC ID: 4789689662 Enrollment ID: I20060927000536 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Kirsten Carlson |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1023115755 PECOS PAC ID: 0941487920 Enrollment ID: I20110531000026 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Shelly Wilson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1275712812 PECOS PAC ID: 8022268523 Enrollment ID: I20121018000272 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Carolyn G Adie |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1982913851 PECOS PAC ID: 1456580851 Enrollment ID: I20140205001328 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Tarin M Gonzales |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1609028281 PECOS PAC ID: 4385967660 Enrollment ID: I20160823002799 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Doreen E Rudman |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1619948171 PECOS PAC ID: 7214987122 Enrollment ID: I20170526001156 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Caroline Ludwig |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1609395136 PECOS PAC ID: 6103191002 Enrollment ID: I20171106002235 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Rachel Colleen Harrison |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1720640105 PECOS PAC ID: 2769712074 Enrollment ID: I20191001000057 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Katherine Margaret Stevens |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1831634211 PECOS PAC ID: 8224465844 Enrollment ID: I20200220002085 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Lisa N Peterkin |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1144882994 PECOS PAC ID: 2860819208 Enrollment ID: I20200831000621 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Mary Ann B Romero |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1144808155 PECOS PAC ID: 7113326448 Enrollment ID: I20210518003099 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Melissa R Wheeler |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1285309120 PECOS PAC ID: 4880091370 Enrollment ID: I20210927001343 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Amber Lampiris-tremba |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1760145676 PECOS PAC ID: 3678961364 Enrollment ID: I20211029000741 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Matthew Vander Kooi |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1477104529 PECOS PAC ID: 4385976133 Enrollment ID: I20221020001099 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Donna Colleen Varan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1780392746 PECOS PAC ID: 7810366168 Enrollment ID: I20221209000014 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Provider Name | Michelle Josephine Parra |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1447537162 PECOS PAC ID: 0840652657 Enrollment ID: I20230810002560 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Active Solutions Therapy Serv Inc Po Box 896, Edgewood, NM 87015-0896 Ph: (505) 286-7838 | Active Solutions Therapy Serv Inc 1 Linnie Ct, Edgewood, NM 87015-9125 Ph: (505) 286-7838 |
News Archive
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.
Consumer Driven Health Plans (CDHPs) in the U.S. experienced continued growth this year – albeit at a slower rate than in 2009 – according to preliminary results released by United Benefit Advisors (UBA) from its 2010 UBA Health Plan Survey, the nation's largest health plan benchmarking survey, with 17,113 plans from 11,413, employers.
An international group of researchers has made a decisive step towards creating the technology to achieve simulations of brain-scale networks on future supercomputers of the exascale class.
The measure would allow vets to seek private care if they couldn't be seen quickly by the VA and requires an evaluation of the VA health system.
› Verified 3 days ago
Dr. Gavin Lynch, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1851 Old Us 66 Ste B, Edgewood, NM 87015 Phone: 505-281-8463 | |
Mrs. Paula A Jones-irvin, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3 George Ct, Suite A, Edgewood, NM 87015 Phone: 505-281-8463 Fax: 505-281-8469 | |
Mary Ann B Romero, PHYSICAL THERAPIST Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1 Linnie Ct Ste Apt, Edgewood, NM 87015 Phone: 505-286-7838 Fax: 505-286-8025 | |
Melissa Rochelle Wheeler, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1 Linnie Ct, Edgewood, NM 87015 Phone: 505-286-7838 Fax: 505-286-8025 | |
Michelle Josephine Parra, P.T. Physical Therapist Medicare: Medicare Enrolled Practice Location: 1 Linnie Ct, Edgewood, NM 87015 Phone: 505-286-7838 | |
Mrs. Rona H Vanwilligen, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1851 Highway 333, 2-b, Edgewood, NM 87015 Phone: 505-281-8463 Fax: 505-281-8469 | |
Tarin Gonzales, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1 Linnie Ct, Edgewood, NM 87015 Phone: 505-286-7838 |